Effect of Medication Reviews Performed in High Risk Patients

University of Aarhus

Status: Unknown

Conditions: Patients in Highest Medication Error Risk

Treatments: Other: Stratified medication review

Study type: Interventional

Funder types: Other

Identifiers

NCT01819974

MERIS2

Details and patient eligibility

About

The purpose of the study is to examine whether a stratified medication review performed in patients at highest risk of experiencing medication errors have impact on numbers of medication errrors during hospitalization.

Full description

Acutely admitted medical patients will be included after admission. After inclusion and randomization the patients will be risk stratified with an existing algorithm according to risk of medication error. The patients in the intervention group will receive a medication review performed by a clinical pharmacist if they are in high medication error risk. Patients in highest medication error risk will recieve a medication review performed by a clinical pharmacologist.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Acutely admitted
• >17 years
• Patients being treated with at least one drug at admission

Exclusion criteria

• Dying patients
• Suicidal patients
• Intoxicated patients

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

600 participants in 2 patient groups

Control

No Intervention group

Description:

The normal procedure at the ward

Stratified medication review

Active Comparator group

Description:

Medication review performed by either a clinical pharmacist or a clinical pharmacologist in patients with highest medication error risk

Treatment:

Other: Stratified medication review